1 – 8 of 8
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden : an observer-masked, randomised controlled trial
(
- Contribution to journal › Article
- 2017
-
Mark
The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers : Study protocol for a randomised controlled trial
(
- Contribution to journal › Article
- 2016
-
Mark
Glucose-Dependent Insulinotropic Polypeptide (GIP) Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.
(
- Contribution to journal › Article
- 2014
-
Mark
Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes
(
- Contribution to journal › Article
- 2012
-
Mark
New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
(
- Contribution to journal › Article
- 2011
-
Mark
Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes
(
- Contribution to journal › Article
- 2009
-
Mark
Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
(
- Contribution to journal › Article
- 2008
-
Mark
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
(
- Contribution to journal › Article